VVOS
Vivos Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.24
-0.06 ▼ -4.62%
🌙 3월 13일 5:21 PM ET (한국 3/14 06:21)
$1.28
+0.04 ▲ +3.56%
| Index | - | P/E | - | EPS (ttm) | -1.97 | Insider Own | 24.25% | Shs Outstand | 0.01B | Perf Week | -6.77% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 34.36% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -25.75% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.49 | Inst Own | 6.29% | Short Float | 6.04% | Perf Quarter | -43.38% |
| Income | -0.02B | P/S | 0.75 | EPS this Y | 12.16% | Inst Trans | -0.47% | Short Ratio | 3.89 | Perf Half Y | -65.93% |
| Sales | 0.02B | P/B | 4.05 | EPS next 5Y | - | ROA | -83.45% | Short Interest | 0.48M | Perf YTD | -38.92% |
| Book/sh | 0.31 | P/C | 4.2 | EPS past 3/5Y | 54.71% 32.77% | ROE | -335.47% | 52W High | -84.4% ($7.95) | Perf Year | -60.76% |
| Cash/sh | 0.3 | P/FCF | - | Sales past 3/5Y | -3.8% 5.7% | ROIC | -123.03% | 52W Low | -1.59% ($1.26) | Perf 3Y | -85.63% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 60.09% | Gross Margin | 49.9% | Volatility(W/M) | 9.98% 9.32% | Perf 5Y | -99.33% |
| Dividend TTM | - | EV/Sales | 1.29 | Sales Y/Y TTM | 18.76% | Oper. Margin | -94.26% | ATR (14) | 0.13 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.78 | EPS Q/Q | -24.53% | Profit Margin | -98.77% | RSI (14) | 29.34 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.78 | Sales Q/Q | 75.73% | SMA20 | -13.97% ($1.44) | Beta | 6.96 | Target Price | $4 |
| Payout | - | Debt/Eq | 4.94 | Earnings | 11000000 | SMA50 | -27.28% ($1.71) | Rel Volume | 1.76 | Prev Close | $1.3 |
| Employees | 109 | LT Debt/Eq | 4.49 | EPS/Sales Surpr. | 3.92% 43.95% | SMA200 | -57.93% ($2.95) | Avg Volume(3M) | 0.12M | Price | $1.24 |
| IPO | 2020/12/11 | Option/Short | No/Yes | Trades | 784 | Volume | 216,022 | Change | -4.62% |
뉴스 로딩 중...